J. Jernigan

发表

Automated hand hygiene count devices may better measure compliance than human observation.

Kerri A. Thom, D. Morgan, L. Pineles, 2012, American journal of infection control.

Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureus

Patrick R. Murray, Wenming Zhu, L. Barth Reller, 2010, Antimicrobial Agents and Chemotherapy.

The changing face of surveillance for health care-associated infections.

John Jernigan, D. Cardo, J. Jernigan, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020

Anne Kimball, A. Baer, J. Duchin, 2020, MMWR. Morbidity and mortality weekly report.

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Anne Kimball, J. Duchin, J. Jernigan, 2020, The New England journal of medicine.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

S. Berenholtz, D. Classen, R. Weinstein, 2014, Infection Control & Hospital Epidemiology.

Methicillin-resistant Staphylococcus aureus disease in three communities.

R. Lynfield, J. Jernigan, S. Fridkin, 2005, The New England journal of medicine.

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit

Kim F. Wong, Susan S. Huang, Bruce Y. Lee, 2016, American journal of epidemiology.

SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus

Carlene A. Muto, J. Jernigan, J. Boyce, 2003, Infection Control & Hospital Epidemiology.

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial*

Victoria J. Fraser, Trish M. Perl, Gianna Zuccotti, 2009, Critical care medicine.

C. P. Quinn, C. Omenaca, D. S. Stephens, 2001, Emerging infectious diseases.

Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

J. Jernigan, S. Fridkin, A. Srinivasan, 2016, JAMA internal medicine.

Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.

Richard Platt, Susan S. Huang, Susan S Huang, 2007, The Journal of infectious diseases.

The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients: a randomized trial.

Bryan Simmons, John Jernigan, E. Wong, 2008, Annals of internal medicine.

The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line–Associated Bloodstream Infections

D. Kleinbaum, J. Jernigan, Ronda L Cochran, 2015, Infection Control & Hospital Epidemiology.

SARS Clinical Features, United States, 2003

P. Patel, J. Jernigan, R. Hoekstra, 2005, Emerging infectious diseases.

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.

M. Klein, J. Jernigan, C. Diazgranados, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.

J. Jernigan, C. Diazgranados, 2005, The Journal of infectious diseases.

Strategies for Clinical Management of MRSA in the Community: Summary of an Experts' Meeting Convened by the Centers for Disease Control and Prevention

J. Powers, J. Jernigan, D. Jernigan, 2006 .

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

T. Rea, M. Sayre, A. Baer, 2020, The New England journal of medicine.

Control of Methicillin-Resistant Staphylococcus aureus at a University Hospital: One Decade Later

G. A. Stott, J. Jernigan, B. Farr, 1995, Infection Control & Hospital Epidemiology.

Sample Size Estimates for Cluster-Randomized Trials in Hospital Infection Control and Antimicrobial Stewardship

L. Magder, L. Pineles, J. Jernigan, 2019, JAMA network open.

Foundations of the Severe Acute Respiratory Syndrome Preparedness and Response Plan for Healthcare Facilities

D. Cardo, L. Chiarello, J. Jernigan, 2004, Infection Control & Hospital Epidemiology.

Mupirocin resistance.

J. Jernigan, J. Patel, R. Gorwitz, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intervention to reduce transmission of resistant bacteria in intensive care.

Matthew Samore, M. Samore, J. Jernigan, 2011, The New England journal of medicine.

Targeted Versus Universal Decolonization to Prevent ICU Infection

Susan S. Huang, R. Platt, R. Weinstein, 2014 .

Clinical findings for fungal infections caused by methylprednisolone injections.

J. Jernigan, M. Kainer, S. Zaki, 2013, The New England journal of medicine.

Possible Horizontal Transfer of thevanB2 Gene among Genetically Diverse Strains of Vancomycin-Resistant Enterococcus faecium in a Korean Hospital

J. Jernigan, F. Tenover, J. Rasheed, 2001, Journal of Clinical Microbiology.

Transmission of SARS-CoV-2 Involving Residents Receiving Dialysis in a Nursing Home — Maryland, April 2020

J. Jernigan, S. Reddy, S. Novosad, 2020, MMWR. Morbidity and mortality weekly report.

Vascular Access and Risk of Bloodstream Infection Among Older Incident Hemodialysis Patients

P. Patel, J. Jernigan, Sophia V. Kazakova, 2020, Kidney medicine.

Pathology and pathogenesis of bioterrorism-related inhalational anthrax.

T. Popović, J. Guarner, D. Ashford, 2003, The American journal of pathology.

Evaluating Patient Adherence to Routine and Symptom Indicated Colonoscopies During the COVID-19 Pandemic

J. Jernigan, M. Mason, K. Vedhanayagam, 2021, Cureus.

Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington.

J. Duchin, J. Jernigan, T. Dellit, 2020, JAMA internal medicine.

Facility-Wide Testing for SARS-CoV-2 in Nursing Homes — Seven U.S. Jurisdictions, March–June 2020

L. Epstein, J. Jernigan, Kelly M. Hatfield, 2020, MMWR. Morbidity and mortality weekly report.

Factors Associated with Antimicrobial Use in Nursing Homes: A Multilevel Model

J. Jernigan, C. Richards, D. Bratzler, 2008, Journal of the American Geriatrics Society.

Randomizing Hospitals to Test Methods for Prevention of Healthcare-Associated Infections

R. Platt, K. Kleinman, J. Jernigan, 2010 .

Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014

N. Arinaminpathy, D. Swerdlow, J. Jernigan, 2016, Emerging infectious diseases.

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel

D. Swerdlow, J. Jernigan, E. Azhar, 2016, Emerging infectious diseases.

Accurate Clinical Prediction of Severe Acute Respiratory Syndrome: Are We There Yet?

J. Jernigan, U. Parashar, R. Helfand, 2004, Annals of Internal Medicine.

Control of Methicillin-Resistant Staphylococcus aureus at a University Hospital: One Decade Later

G. A. Stott, J. Jernigan, B. Farr, 1995, Infection Control & Hospital Epidemiology.

Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Carriage in Residents of Veterans Affairs Long-Term Care Facilities: Role of Antimicrobial Exposure and MRSA Acquisition

R. Gaynes, J. Jernigan, J. Mcgowan, 2012, Infection Control & Hospital Epidemiology.

Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks — Minnesota, April–June 2020

Lisa A. Jacobson, R. Lynfield, J. Jernigan, 2020, MMWR. Morbidity and mortality weekly report.

Implications for Public Health: Hospital administrators and health-care providers can reduce potential harm and risk for antibiotic resistance by implementing formal programs to improve antibiotic prescribing in hospitals. Vital Signs: Improving Antibiotic Use Among Hospitalized Patients

R. Fagan, M. Samore, J. Meek, 2014 .

Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults — Seattle, Washington, 2020

J. Duchin, L. Schieve, J. Jernigan, 2020, MMWR. Morbidity and mortality weekly report.

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals.

J. Jernigan, L. McDonald, Sarah H. Yi, 2016, American journal of infection control.

Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States

J. Jernigan, A. Srinivasan, Kelly M. Hatfield, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring health care workers after smallpox vaccination: findings from the Hospital Smallpox Vaccination-Monitoring System.

D. Cardo, J. Jernigan, J. Tokars, 2005, American journal of infection control.

Importance of Bacterial Burden Among Methicillin-Resistant Staphylococcus aureus Carriers in a Long-Term Care Facility

R. Gaynes, J. Jernigan, J. Mcgowan, 2008, Infection Control & Hospital Epidemiology.

A Randomized Crossover Study of Disposable Thermometers for Prevention of Clostridium difficile and Other Nosocomial Infections

J. Jernigan, B. Farr, Y. Siegman-Igra, 1998, Infection Control & Hospital Epidemiology.

Clinical Incidence of Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization or Infection as a Proxy Measure for MRSA Transmission in Acute Care Hospitals

K. Ellingson, J. Jernigan, A. Kallen, 2011, Infection Control & Hospital Epidemiology.

Methicillin-resistant Staphylococcus aureus colonization among health care personnel in the emergency department: what does it tell us?

J. Jernigan, 2008, Annals of emergency medicine.

the assessment vancomycin-resistant enterococci by routine screening.

S. Cosgrove, J. Jernigan, D. Yokoe, 2007 .

Association Between Mucositis Severity and Vancomycin-Resistant Enterococcal Bloodstream Infection in Hospitalized Cancer Patients

J. Jernigan, D. Rimland, M. Kuehnert, 1999, Infection Control & Hospital Epidemiology.

Toxic Shock Associated With Clostridium sordellii and Clostridium perfringens After Medical and Spontaneous Abortion

T. Kwan-Gett, J. Duchin, J. Guarner, 2007, Obstetrics and gynecology.

Identification of Leishmania chagasi antigens recognized by human lymphocytes.

R. Pearson, J. Jernigan, T. Vedvick, 1995, The Journal of infectious diseases.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

R. Link-Gelles, S. Schrag, J. Jernigan, 2021, MMWR. Morbidity and mortality weekly report.

Reply to Nannini and to a previous letter by Hurley.

J. Jernigan, C. Diazgranados, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022

J. Jernigan, Yoojin Lee, S. Gravenstein, 2022, MMWR. Morbidity and mortality weekly report.

1236The Preventability of Ventilator-Associated Events: The CDC Prevention Epicenters' Wake Up and Breathe Collaborative

Barrett T. Kitch, M. Balas, R. Platt, 2014, American journal of respiratory and critical care medicine.

Reply to Dinh et al.

J. Jernigan, A. Srinivasan, Kelly M. Hatfield, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of and Risk Factors for Colonization With Methicillin-Resistant Staphylococcus aureus in an Outpatient Clinic Population

J. Jernigan, W. Jarvis, Amy L Pullen, 2003, Infection Control & Hospital Epidemiology.

Systems for Rapidly Detecting and Treating Persons with Ebola Virus Disease — United States

C. Whitney, J. Jernigan, G. Margolis, 2015, MMWR. Morbidity and mortality weekly report.

Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy

J. Jernigan, Mark D. King, J. Cinnamon, 2002, International journal of STD & AIDS.

Characteristics of nursing home residents and healthcare personnel with repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests positive ≥90 days after initial infection: Four US jurisdictions, July 2020–March 2021

J. Jernigan, A. Tamin, S. Tong, 2022, Infection control and hospital epidemiology.

Evaluating the Presence of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Nursing Home Residents With Persistently Positive Reverse Transcription Polymerase Chain Reaction (RT-PCR) Results

J. Jernigan, A. Tamin, J. Harcourt, 2021, Clinical Infectious Diseases.

Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing Home Residents with Persistently Positive RT-PCR Results

J. Jernigan, A. Tamin, J. Harcourt, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities — Detroit, Michigan, March–May 2020

J. Jernigan, P. Kilgore, M. Zervos, 2020, MMWR. Morbidity and mortality weekly report.

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause infections in units (ABATE Infection trial): a cluster-randomised trial.

R. Weinstein, K. Kleinman, J. Jernigan, 2019 .

Fungal Infections Associated with Contaminated Methylprednisolone Injections — Preliminary Report

J. Jernigan, M. Kainer, D. Blau, 2012 .

Surgical site infection risk following cesarean deliveries covered by Medicaid or private insurance

D. Kleinbaum, J. Jernigan, Sophia V. Kazakova, 2019, Infection control and hospital epidemiology.

artizle-Tropical infection ofthe gasroiestn tract and lier series Parasitic infections of the small intestine

J. Jernigan, 2006 .

Parasitic infections of the small intestine.

R. Pearson, J. Jernigan, R. Guerrant, 1994, Gut.

D. Ashford, J. Jernigan, D. Stephens, 2003, Emerging infectious diseases.

Declines in the utilization of hospital‐based care during COVID‐19 pandemic

J. Jernigan, A. Harris, Sophia V. Kazakova, 2022, Journal of hospital medicine.

COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020

Atar Baer, Eric J Chow, Meagan Kay, 2020, MMWR. Morbidity and mortality weekly report.

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus

M. Samore, J. Jernigan, R. Nelson, 2017, Infection Control & Hospital Epidemiology.

Targeted versus universal decolonization to prevent ICU infection.

R. Platt, R. Weinstein, K. Kleinman, 2013, The New England journal of medicine.

In vitro activity of atovaquone against Leishmania chagasi promastigotes

R. Pearson, J. Jernigan, W. Petri, 1996, Antimicrobial agents and chemotherapy.

Prevalence of and Risk Factors for Colonization With Methicillin-Resistant Staphylococcus aureus at the Time of Hospital Admission

J. Jernigan, W. Jarvis, Amy L Pullen, 2003, Infection Control & Hospital Epidemiology.

Fungal infections associated with contaminated methylprednisolone injections.

J. Jernigan, M. Kainer, D. Blau, 2013, The New England journal of medicine.

Modeling regional transmission and containment of a healthcare-associated multidrug-resistant organism.

J. Jernigan, A. Kallen, R. Slayton, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SHEA Guideline for Preventing Nosocomial Transmission

Carlene A. Muto, J. Jernigan, J. Boyce, 2003 .

Survey of employee knowledge and attitudes before and after a multicenter Veterans' Administration quality improvement initiative to reduce nosocomial methicillin-resistant Staphylococcus aureus infections.

Michael J Fine, M. Fine, J. Jernigan, 2010, American journal of infection control.

Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.

Prabasaj Paul, Richard E Nelson, Anthony Fiore, 2020, The New England journal of medicine.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States

John Jernigan, Marion A. Kainer, Isaac See, 2019, MMWR. Morbidity and mortality weekly report.

Effect of daily chlorhexidine bathing on hospital-acquired infection.

E. Wong, K. Sepkowitz, R. Weinstein, 2013, The New England journal of medicine.

Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.

J. Jernigan, M. Render, R. Freyberg, 2011, The New England journal of medicine.

Does Chlorhexidine Bathing in Adult Intensive Care Units Reduce Blood Culture Contamination? A Pragmatic Cluster-Randomized Trial

R. Weinstein, K. Kleinman, J. Perlin, 2014, Infection Control & Hospital Epidemiology.

Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.

J. Jernigan, J. Edwards, T. Horan, 2009, JAMA.

An urban outbreak of visceral leishmaniasis in Natal, Brazil.

R. Pearson, J. Jernigan, S. Jeronimo, 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons*

Sameer S. Kadri, David J Murphy, C. Seymour, 2019, Critical care medicine.

Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.

W. Schaffner, S. Schrag, R. Lynfield, 2023, The Journal of infectious diseases.

Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021

S. Schrag, J. Jernigan, S. Parikh, 2021, MMWR. Morbidity and mortality weekly report.

Kirschke DL, Jones TF, Craig AS, Chu PS, Mayernick GG, Patel JA, Schaffner W. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med

D. Swerdlow, J. Hadler, J. Jernigan, 2003 .

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

Susan Gruber, Edward Septimus, Theodore J. Iwashyna, 2017, JAMA.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

Sean M Berenholtz, Robert Wise, Michael Klompas, 2014, Infection Control & Hospital Epidemiology.

A research framework for reducing preventable patient harm.

D. Cardo, P. Pronovost, S. Berenholtz, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial

R. Platt, R. Weinstein, K. Kleinman, 2019, The Lancet.

National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.

R. Scott, M. Samore, J. Jernigan, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between Antibiotic Use and Hospital-Onset Clostridioidesdifficile Infection in U.S. Acute Care Hospitals, 2006-2012: an Ecologic Analysis.

J. Jernigan, L. McDonald, Sophia V. Kazakova, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial Infections Associated with Substance Use Disorders, Large Cohort of United States Hospitals, 2012-2017.

J. Jernigan, A. Fiore, I. See, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vital Signs: Improving Antibiotic Use Among Hospitalized Patients

R. Fagan, M. Samore, J. Meek, 2014, MMWR. Morbidity and mortality weekly report.

Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure

L. Epstein, J. Jernigan, L. McDonald, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.

J. Jernigan, S. Fridkin, F. Tenover, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings: SHEA/HICPAC Position Paper

R. Weinstein, J. Jernigan, S. Fridkin, 2008, Infection Control & Hospital Epidemiology.

Effect of nonpayment for preventable infections in U.S. hospitals.

R. Platt, A. Jha, K. Kleinman, 2012, The New England journal of medicine.

Daily Chlorhexidine Bathing-Effect on Healthcare-associated BSI and MDRO Acquisition

E. Wong, R. Weinstein, D. Warren, 2017 .

Association of Hospital-Onset Clostridium difficile Infection Rates and Antibiotic Use in US Acute Care Hospitals, 2006–2012: An Ecologic Analysis

J. Jernigan, L. McDonald, Sophia V. Kazakova, 2017, Open Forum Infectious Diseases.

National Estimates of Central Line–Associated Bloodstream Infections in Critical Care Patients

R. Scott, K. Ellingson, J. Jernigan, 2013, Infection Control & Hospital Epidemiology.

The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California.

Leslie E. Mueller, Bruce Y. Lee, V. Mor, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chemotherapy of leishmaniasis, Chagasʼ disease and African trypanosomiasis

R. Pearson, J. Jernigan, 1993 .

Implementation of an Industrial Systems-Engineering Approach to Reduce the Incidence of Methicillin-Resistant Staphylococcus aureus Infection

J. Jernigan, C. Squier, R. Sinkowitz-Cochran, 2008, Infection Control & Hospital Epidemiology.

Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)

D. Cardo, K. Krause, B. Allegranzi, 2019, Antimicrobial Resistance & Infection Control.

Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1)

D. Cardo, K. Krause, B. Allegranzi, 2019, Antimicrobial Resistance & Infection Control.

Activity of Commonly Used Antimicrobial Prophylaxis Regimens against Pathogens Causing Coronary Artery Bypass Graft and Arthroplasty Surgical Site Infections in the United States, 2006–2009

J. Jernigan, A. Ma, D. Bratzler, 2014, Infection Control & Hospital Epidemiology.

Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

Anthony Fiore, Lacey Avery, Raymund B. Dantes, 2016, MMWR. Morbidity and mortality weekly report.

Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries With Hospitalizations for Severe Sepsis and Septic Shock*

Raymund B. Dantes, L. Epstein, M. Sapiano, 2018, Critical care medicine.

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreaks in nursing homes involving residents who had completed a primary coronavirus disease 2019 (COVID-19) vaccine series-13 US jurisdictions, July-November 2021.

J. Jernigan, A. Kallen, Kelly M. Hatfield, 2023, Infection control and hospital epidemiology.

SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022

J. Jernigan, L. McDonald, E. Mylonakis, 2023, MMWR. Morbidity and mortality weekly report.

SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member – Connecticut, July–August 2021

J. Tate, J. Jernigan, H. Kirking, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes

J. Jernigan, R. Kahn, M. Mina, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fatal inhalational anthrax in a 94-year-old Connecticut woman.

Tanja Popovic, T. Popović, D. Swerdlow, 2002, JAMA.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

J. Jernigan, S. Fridkin, S. Romero-Steiner, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae

Kim F. Wong, Bruce Y. Lee, J. Jernigan, 2016, Journal of Clinical Microbiology.

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers

A. Amin, R. Platt, R. Weinstein, 2019, The New England journal of medicine.

Modeling effectiveness of testing strategies to prevent COVID-19 in nursing homes —United States, 2020

J. Jernigan, A. Srinivasan, N. Stone, 2020, medRxiv.

Cluster Randomized Trials in Comparative Effectiveness Research: Randomizing Hospitals to Test Methods for Prevention of Healthcare-Associated Infections

Richard Platt, Ken Kleinman, Edward Septimus, 2010, Medical care.

Title Cluster randomized trials in comparative effectiveness research : randomizing hospitals to test methods for prevention of healthcare-associated infections

R. Platt, K. Kleinman, J. Perlin, 2010 .

Combining Clinical and Epidemiologic Features for Early Recognition of SARS

J. Jernigan, D. Low, R. Helfand, 2004, Emerging infectious diseases.

Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial

R. Platt, R. Weinstein, K. Kleinman, 2016, Journal of Clinical Microbiology.

Unnecessary Use of Central Venous Catheters: The Need to Look Outside the Intensive Care Unit

William E Trick, Mary F. Wisniewski, W. Trick, 2004, Infection Control & Hospital Epidemiology.

Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers — United States, 2005–2017

M. Samore, J. Jernigan, Kelly M. Hatfield, 2019, MMWR. Morbidity and mortality weekly report.

Trends in antifungal use in US hospitals, 2006–12

Brendan R. Jackson, B. Jackson, J. Jernigan, 2018, The Journal of antimicrobial chemotherapy.

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates.

S. Berenholtz, D. Classen, R. Weinstein, 2014, American journal of infection control.

Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial.

R. Platt, R. Weinstein, K. Kleinman, 2016, The Lancet. Infectious diseases.

The associations between organizational culture and knowledge, attitudes, and practices in a multicenter Veterans Affairs quality improvement initiative to prevent methicillin-resistant Staphylococcus aureus.

M. Fine, J. Jernigan, D. Obrosky, 2012, American journal of infection control.

The Cost–Benefit of Federal Investment in Preventing Clostridium difficile Infections through the Use of a Multifaceted Infection Control and Antimicrobial Stewardship Program

R. Scott, J. Jernigan, F. Lessa, 2015, Infection Control & Hospital Epidemiology.

Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses.

Dori B. Reissman, Dori B Reissman, C. Bridges, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Study of the Impact of Community-Onset Clostridium difficile Infection on Surveillance for C. difficile Infection

B. Hota, J. Jernigan, V. Fraser, 2009, Infection Control & Hospital Epidemiology.

Sustained Reduction in the Clinical Incidence of Methicillin-Resistant Staphylococcus aureus Colonization or Infection Associated with a Multifaceted Infection Control Intervention

D. Kleinbaum, V. Gebski, K. Ellingson, 2011, Infection Control & Hospital Epidemiology.

Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)

K. Krause, B. Allegranzi, D. Pittet, 2019, Antimicrobial Resistance and Infection Control.

Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report.

P. Patel, J. Jernigan, A. Kallen, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals

R. Scott, J. Jernigan, F. Lessa, 2019, Antimicrobial Resistance & Infection Control.

Title Recommendations for metrics for multidrug-resistant organisms in healthcare settings : SHEA / HICPAC position paper Permalink

J. Jernigan, S. Fridkin, D. Calfee, 2014 .

Control of vancomycin-resistant Enterococcus in health care facilities in a region

J. Jernigan, 2002, Current infectious disease reports.

Improving the assessment of vancomycin-resistant enterococci by routine screening.

S. Cosgrove, R. Platt, J. Jernigan, 2007, The Journal of infectious diseases.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic‐Resistant Infections in Health Care Facilities — United States

Kim F. Wong, Bruce Y. Lee, M. Samore, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Intervention to Reduce Transmission of Resistant Bacteria in Intensive Care

Matthew H. Samore, Patrick R. Murray, Donald A. Goldmann, 2012 .

Chronic Q Fever with Vascular Involvement: Progressive Abdominal Pain in a Patient with Aortic Aneurysm Repair in the United States

J. Jernigan, G. Kersh, K. J. Jacobs Slifka, 2019, Case reports in infectious diseases.

Public Disclosure of Healthcare-Associated Infections: The Role of the Society for Healthcare Epidemiology of America

E. Wong, M. Rupp, J. Jernigan, 2005, Infection Control & Hospital Epidemiology.

Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty.

J. Jernigan, S. Culler, J. Baggs, 2015, The Journal of arthroplasty.

The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities

Matthew H Samore, Adi V Gundlapalli, Karim Khader, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States

Kim F. Wong, Bruce Y. Lee, M. Samore, 2015, MMWR. Morbidity and mortality weekly report.

Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort

D. Kleinbaum, P. Patel, J. Jernigan, 2016, Infection Control & Hospital Epidemiology.

Evaluation of Organizational Culture among Different Levels of Healthcare Staff Participating in the Institute for Healthcare Improvement's 100,000 Lives Campaign

G. Baker, S. Ostroff, M. Klompas, 2012, Infection Control & Hospital Epidemiology.

Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing Home

J. Duchin, J. Jernigan, A. Bardossy, 2021, Journal of the American Medical Directors Association.

Signs, Symptoms, and Comorbidities Associated with Poor Outcomes among Residents of a Skilled Nursing Facility with SARS-CoV-2 Infection—King County, Washington

J. Duchin, J. Jernigan, A. Bardossy, 2021, Journal of the American Medical Directors Association.

Decolonization to Prevent Infections with Staphylococcus aureus in Patients Undergoing Hemodialysis: A Review of Current Evidence

P. Patel, J. Jernigan, A. Kallen, 2011, Seminars in dialysis.

Eradicating nasal carriage of staphylococcus aureus as a strategy for preventing health care-associated infections in nonsurgical patients

J. Jernigan, 2004, Current infectious disease reports.

Is the Burden of Staphylococcus aureus Among Patients With Surgical-Site Infections Growing?

J. Jernigan, 2004, Infection Control & Hospital Epidemiology.

Current Practice in Staphylococcus aureus Screening and Decolonization

P. Polgreen, J. Jernigan, A. Kallen, 2011, Infection Control & Hospital Epidemiology.

Vital Signs: Preventing Antibiotic‐Resistant Infections in Hospitals — United States, 2014

J. Jernigan, J. Edwards, S. Fridkin, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

J. Jernigan, J. Edwards, S. Fridkin, 2016, MMWR. Morbidity and mortality weekly report.

Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak

J. Jernigan, L. McDonald, Jonathan Bryant-Genevier, 2021, Annals of Internal Medicine.

Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1)

D. Cardo, K. Krause, B. Allegranzi, 2019, Antimicrobial Resistance & Infection Control.

Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.

J. Jernigan, R. Waldman, C. Cusumano, 1975, Journal of the National Cancer Institute.

The CDC SHIELD Orange County Project – Baseline Multi Drug-Resistant Organism (MDRO) Prevalence in a Southern California Region

R. Platt, R. Weinstein, K. Kleinman, 2017, Open Forum Infectious Diseases.

The importance of ventilator skilled nursing facilities (vSNFs) in the regional epidemiology of carbapenemase-producing organisms (CPOs)

Michael Y. Lin, W. Trick, R. Weinstein, 2017 .

Knowledge, Attitudes, and Behaviors Regarding Piperacillin-Tazobactam Prescribing Practices: Results From a Multicenter Study

D. Cardo, R. Gaynes, J. Jernigan, 2006, Infection Control & Hospital Epidemiology.

Trends in facility-level rates of Clostridioides difficile infections in US hospitals, 2019–2020

J. Jernigan, Sophia V. Kazakova, J. Baggs, 2022, Infection Control & Hospital Epidemiology.

Enhancement of health department capacity for health care-associated infection prevention through Recovery Act-funded programs.

K. Ellingson, J. Jernigan, K. Rask, 2014, American journal of public health.

EnhancementofHealthDepartmentCapacityforHealth Care-AssociatedInfectionPreventionThroughRecovery Act-FundedPrograms

K. Ellingson, J. Jernigan, K. Rask, 2014 .

Perceived impact of the Medicare policy to adjust payment for health care-associated infections.

S. Saint, A. Jha, J. Jernigan, 2012, American journal of infection control.

Medicare Reimbursement Attributable to Catheter-associated Urinary Tract Infection in the Inpatient Setting: A Retrospective Cohort Analysis

R. Scott, J. Jernigan, C. Gould, 2014, Medical care.

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection

J. Jernigan, L. McDonald, A. Srinivasan, 2018, Open Forum Infectious Diseases.

Hand Hygiene Practices After Brief Encounters With Patients: An Important Opportunity for Prevention

D. Cardo, J. Jernigan, R. Sinkowitz-Cochran, 2007, Infection Control & Hospital Epidemiology.

4. 137 Hospital Cluster-Randomized Trial of Mupirocin-Chlorhexidine vs Iodophor-Chlorhexidine for Universal Decolonization in Intensive Care Units (ICUs) (Mupirocin Iodophor Swap Out Trial)

R. Platt, K. Sands, R. Weinstein, 2021, Open Forum Infectious Diseases.

Evaluation and Validation of a Real-Time Polymerase Chain Reaction Assay for Rapid Identification of Bacillus anthracis

Tanja Popovic, John A. Jernigan, Richard F. Meyer, 2002, Emerging infectious diseases.

CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008.

R. Scott, J. Jernigan, L. McDonald, 2014, Health affairs.

Aiming for zero: Is complete elimination of catheter-related bloodstream infections among intensive care unit patients a realistic goal?

J. Jernigan, 2005, Current infectious disease reports.

Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus.

J. Jernigan, B. Farr, B M Farr, 1996, American journal of epidemiology.

Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control.

F. Hayden, J. Jernigan, B. Conway, 1993, The Journal of infectious diseases.

Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature.

J. Jernigan, B. Farr, J. Jernigan, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An Agent-Based Model for Evaluating Surveillance Methods for Catheter-Related Bloodstream Infection

Jeanmarie Mayer, Matthew H. Samore, Brian C. Sauer, 2008, AMIA.

Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.

M. Cetron, J. Jernigan, J. Roberts, 2000, The Journal of infectious diseases.

Multicenter Study of the Impact of Community-Onset Clostridium difficile Infection on Surveillance for C. difficile Infection

Bala N Hota, B. Hota, J. Jernigan, 2009, Infection Control & Hospital Epidemiology.

Fatal inhalational anthrax in a 94-year-old Connecticut woman.

T. Popović, D. Swerdlow, J. Hadler, 2002, JAMA.

Mupirocin resistance.

J. Jernigan, J. Patel, R. Gorwitz, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial.

J. Jernigan, Micaela H. Coady, Taliser R. Avery, 2023, JAMA.

Duration of colonization with methicillin-resistant Staphylococcus aureus in an acute care facility: a study to assess epidemiologic features.

R. Gaynes, J. Jernigan, D. Rimland, 2014, American journal of infection control.

Effect of nonpayment for preventable infections in U.S. hospitals.

R. Platt, A. Jha, K. Kleinman, 2012, The New England journal of medicine.

Targeted versus universal decolonization to prevent ICU infection.

R. Platt, R. Weinstein, K. Kleinman, 2013, The New England journal of medicine.

Morbidity and Mortality Weekly Report Vital Signs: Improving Antibiotic Use among Hospitalized Patients

R. Fagan, M. Samore, J. Meek, 2022 .

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018

J. Jernigan, L. McDonald, Sophia V. Kazakova, 2021, Infection Control & Hospital Epidemiology.

ICE volume 35 issue 8 Cover and Front matter

Katherine, Hazen, Aiello, 2014, Infection Control & Hospital Epidemiology.

Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.

J. Jernigan, D. Rimland, A. Hightower, 2000, The Journal of infectious diseases.

Glycopeptide resistance in Staphylococcus aureus

J. Jernigan, 1999, Current Infectious Disease Reports.